Asia-Pacific Enteral Syringe Market Size, Share & Trends Analysis Report by Age Group (Adults and Pediatrics), End User (Hospitals, Ambulatory Surgical Centers, and Homecare), Type (Disposable and Reusable), Country and Growth Forecast, 2024-2031

The Asia Pacific Enteral Syringe Market is projected to witness market growth of 5.6% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Enteral Syringe Market by country in 2023, and is projected to continue to be a dominant market till 2031; thereby, achieving a market value of $45.51 millions by 2031. The Japan market is registering a CAGR of 5.3% during 2024-2031. Additionally, the India market would showcase a CAGR of 6.3% during 2024-2031.



Adopting these syringes has grown significantly due to various factors influencing the healthcare landscape. These factors include the increasing prevalence of conditions requiring enteral nutrition, advancements in medical technology, and shifts in healthcare practices. The development and dissemination of guidelines for enteral nutrition by health organizations and professional societies have led to more widespread use of these syringes. These guidelines emphasize the importance of enteral feeding in managing various medical conditions.

Moreover, training and educational programs for healthcare professionals on using these syringes and enteral nutrition have increased the adoption rate. Enhanced knowledge and skills among practitioners facilitate the effective use of these devices. Increased awareness among patients and caregivers about the benefits of enteral nutrition has also contributed to higher adoption. Patients are more informed about their treatment options and the role of these syringes in their care.

As the elderly population grows, there is a corresponding rise in the number of individuals requiring enteral nutrition. This is due to age-related conditions such as dysphagia (difficulty swallowing), malnutrition, and chronic illnesses that often necessitate the use of these syringes for administering food and medication. To cater to the increasing elderly population, China is likely to expand and improve healthcare facilities and services. This includes the provision of these syringes in hospitals, nursing homes, and home healthcare settings, boosting market demand. The growth of hospitals in India leads to a higher volume of patients requiring enteral nutrition, particularly those with chronic diseases, cancer, and gastrointestinal disorders. This increased patient population drives up the demand for these syringes used for administering nutrition and medication. According to the National Investment Promotion & Facilitation Agency, the hospital sector in India was valued at INR 7.94 trillion in FY21 in terms of revenue and is expected to reach INR 18.34 trillion by FY 2027. Hence, increasing elderly population and expansion of the hospital sector is driving the growth of the market.

Based on Age Group, the market is segmented into Adults and Pediatrics. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Homecare. Based on Type, the market is segmented into Disposable and Reusable. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Boston Scientific Corporation
• Nestlé S.A.
• Fresenius SE & Co. KGaA
• Becton, Dickinson and Company
• Braun Melsungen AG
• Cardinal Health, Inc.
• Moog Inc.
• Cook Medical, Inc.(Cook Group)
• Thermo Fisher Scientific Inc.
• Medela AG

Market Report Segmentation

By Age Group

• Adults
• Pediatrics

By End User

• Hospitals
• Ambulatory Surgical Centers
• Homecare

By Type

• Disposable
• Reusable

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific